Dermatology Excision Billing: The Clinical-to-Payment Journey for CPT 11400–11646

Schedule Your Free Consultation

QUICK ANSWER

The correct excision code is determined by four things together: which code family applies (benign 11400–11446 or malignant 11600–11646), the excised diameter — the lesion plus the narrowest margin on each side, not the visible lesion alone — the anatomical site grouping, and documentation that actually supports all of it. Pathology confirms benign vs. malignant status; it doesn't set the size tier. There's no shortcut that replaces getting all four right on the same claim.

Most excision claim problems aren't submission problems — by the time a claim is denied, the decision that caused it was usually made earlier: at measurement, at documentation, or at code selection. This guide follows the actual path a claim takes, from the clinical encounter to final payment, and flags where our billing team most often sees that path go wrong.

The Excision Claim Lifecycle

Stage	Primary Risk	Quality Control
Clinical evaluation	Incomplete documentation of the lesion itself	Provider documentation review
Procedure planning	Margin plan not clearly established before excision	Pre-procedure documentation check
Procedure	Measurement not taken, or taken after closure	Operative note measurement standard
Pathology	Diagnosis (benign/malignant) not reconciled with the claim	Pathology-to-claim reconciliation
Coding	Wrong code family, tier, or site grouping selected	Coding QA
Claim creation	Modifier or NCCI edit overlooked	Claim scrub
Adjudication	Payer-specific edit triggers a denial	Denial monitoring
Payment	Payment posted below the contracted or expected rate	Payment variance review
Reconciliation	Underpayment or pattern goes unflagged	Periodic revenue audit

When Is an Excision Actually an Excision?

Excision, biopsy, shave removal, destruction, and Mohs surgery are coded from entirely different code families, and mixing them up — or letting documentation language blur the line — is a common source of miscoding:

Procedure	Clinical Purpose	Common Confusion
Excision	Full-thickness removal through the dermis, with margins, as an intact specimen	Confused with a large biopsy or shave
Biopsy	Diagnostic sampling; no definitive diagnosis yet established	Billed as an excision when tissue was actually fully removed, or vice versa
Shave removal	Superficial removal that doesn't extend through full dermal thickness	Coded as an excision despite not meeting full-thickness removal
Destruction	Lesion destroyed (cryotherapy, laser, electrodesiccation) — no intact specimen for pathology	Confused with excision when a specimen was actually sent for pathology
Mohs surgery	Staged, margin-controlled surgery with the same physician acting as surgeon and pathologist	Coded as a standard excision when Mohs technique was actually used
DOCUMENTATION CHECK The word “biopsy” in an operative note for a procedure that was actually a complete excision is one of the more common, entirely avoidable causes of miscoding — the coder can only code what the documentation says was done.

Four Questions Before Selecting an Excision Code

Work Through in Order

1. What procedure was actually performed — excision, biopsy, shave, destruction, or Mohs?

2. What lesion or diagnosis is being treated — and is it confirmed benign, confirmed malignant, or not yet known?

3. What does the applicable code family's measurement rule require — excised diameter, including margins?

4. Does the documentation, read on its own, actually support the code being submitted?

Measuring an Excision Correctly

This is the single most consequential documentation step in excision billing. Excised diameter is not the visible lesion size — it's the lesion's widest clinical diameter plus the narrowest margin taken on each side, and it's measured at the time of excision, before the specimen goes to pathology and before closure.

WORKED EXAMPLE (ILLUSTRATIVE)

A malignant lesion measures 1.0 cm at its widest point before excision. The surgeon takes a 1.0 cm margin on each side to ensure complete removal. Excised diameter = 1.0 cm + (2 × 1.0 cm) = 3.0 cm, reported as 11603 (trunk/arms/legs, 2.1–3.0 cm) if malignant, or the equivalent benign-family code at that size if benign. This is an illustrative calculation only — actual code selection depends on the specific documented measurements and site.

A second, easily missed point: pathology specimens shrink in formalin fixation. The pathology report's measurement is not the number that sets the code — the operative note's pre-excision measurement is. Pathology's role is to confirm what the lesion actually was (benign or malignant), not to re-measure it for coding purposes.

Benign vs. Malignant: A Coding Decision Framework

Factor	Benign Excision (11400–11446)	Malignant Excision (11600–11646)
What sets the family	Pathology-confirmed benign, or no pathology contradicting a benign clinical impression	Pathology confirmation of malignancy — primary, secondary, or in-situ
What sets the size tier	Operative note's pre-excision excised diameter	Operative note's pre-excision excised diameter
If pathology is pending	Many practices code as benign with an indeterminate diagnosis until confirmed	Requires pathology confirmation — don't code malignant on clinical suspicion alone
Audit risk	Diagnosis doesn't match the documented lesion type	Diagnosis billed without a supporting pathology report on file

Never let pathology results retroactively justify documentation that wasn't actually recorded at the time of the procedure — the operative note has to stand on its own.

Anatomical Site Groupings

Both the benign and malignant families use the same three site groupings, so the wrong grouping is an easy, avoidable error:

Site Grouping	Benign Code Range	Malignant Code Range
Trunk, arms, legs	11400–11406	11600–11606
Scalp, neck, hands, feet, genitalia	11420–11426	11620–11626
Face, ears, eyelids, nose, lips, mucous membrane	11440–11446	11640ㄖ46

Within each grouping, six diameter tiers apply in the same pattern: 0.5 cm or less, 0.6–1.0 cm, 1.1–2.0 cm, 2.1–3.0 cm, 3.1–4.0 cm, and over 4.0 cm — the operative note needs to place the excised diameter clearly within one tier, not leave it inferable.

Documentation That Makes an Excision Claim Defensible

Provider Documentation Checklist

☐  Lesion diagnosis or clinical description

☐  Anatomical location, specific enough to place it in the correct site grouping

☐  Pre-excision clinical lesion measurement

☐  Margin taken on each side

☐  Excised diameter (lesion plus margins) explicitly stated, not left for the coder to calculate from ambiguous numbers

☐  Procedure performed, described clearly as an excision

☐  Medical necessity for the procedure

☐  Specimen sent to pathology, and pathology result when available

☐  Closure type performed

☐  Number of lesions, if more than one, each with its own site and measurement

☐  Provider authentication and date of service

Excision Coding QA Checklist

Before Submission

☐  Procedure matches the code selected (excision, not biopsy/shave/destruction/Mohs)

☐  Diagnosis supports the benign or malignant family billed

☐  Anatomical site grouping is correct

☐  Excised diameter, not lesion size alone, supports the tier billed

☐  Margins are documented, not assumed

☐  Multiple procedures reviewed for correct modifier and unit logic

☐  Same-day E/M reviewed for genuine separate identifiability

☐  Pathology reconciled against the diagnosis billed

☐  Closure reviewed — bundled vs. separately reportable

☐  Payer-specific and NCCI edits checked

Same-Day E/M and Excision

A significant, separately identifiable E/M service can be billed the same day as an excision — but modifier 25 isn't automatic just because both occurred on the same date. Routine pre-procedure work (assessing the lesion that's about to be excised, obtaining consent, planning the excision itself) is part of the procedure, not a separately billable E/M. The E/M needs its own supporting content: a distinct complaint, its own medical decision making, documented separately from the procedure note.

Situation	Billing Risk
Procedure only	Low — straightforward procedure documentation
E/M + procedure, both genuinely documented	Modifier and bundling risk if documentation doesn't clearly separate them
New problem evaluated, unrelated to the excised lesion	Documentation risk if the new problem's MDM isn't distinctly recorded
Routine pre-procedure assessment only	Overcoding risk if billed as a separate E/M

Multiple Lesions and Multiple Excisions

Each lesion excision is reported as its own procedure, with its own diagnosis. Multiple lesions in the same code (same size tier, same family) are billed either as multiple units or with modifier 59 on each code after the first, depending on the specific payer's preference — confirm which before submitting.

COMMON CODING TRAP

Closures require their own logic. If two or more excisions in the same session need the same type of closure (both intermediate, for example) at anatomic sites grouped into the same closure code range, the lengths are added together and billed as one closure code — not one closure code per excision. Different closure types (one intermediate, one complex) or different closure-code groupings are billed separately instead.

Closure Coding After Excision

Simple closure is bundled into every excision code in the 11400–11646 range — it's never billed separately, regardless of size or family. CPT's own instruction is that intermediate and complex closure should be reported separately when performed.

COMPLIANCE WATCH

There's a genuine, well-documented conflict between CPT instruction and Medicare's NCCI edits on this exact point: for the smallest tier in each anatomic grouping specifically — 11400, 11420, and 11440, the benign codes for an excised diameter of 0.5 cm or less — NCCI bundles simple, intermediate, and complex closure into the excision code, even though CPT's general instruction says otherwise. Modifier 59 does not reliably override this for Medicare claims at that specific size tier, and appending it without a genuinely separate circumstance to document is not a safe workaround. Above that smallest tier, and for the malignant family generally, intermediate and complex closure remain separately reportable under CPT instruction — but always confirm current NCCI status and payer-specific policy before assuming either way.

Diagnosis-to-CPT Alignment

The diagnosis billed has to reflect what pathology and the clinical record actually support — a benign-lesion diagnosis paired with a malignant excision code, or vice versa, is an immediate mismatch. When the clinical diagnosis is genuinely uncertain at the time of the procedure, many practices code as benign with an indeterminate or unspecified diagnosis until pathology returns, then correct the claim if needed — rather than coding malignant on suspicion alone. Coverage and medical necessity for cosmetic-adjacent removals varies by payer and by specific LCD; a lesion removed for purely cosmetic reasons, without a qualifying medical-necessity diagnosis, is a coverage question separate from which CPT code technically describes the procedure.

How Pathology Should Interact With Billing

Procedure → claim preparation → pathology result → coding validation → claim correction if necessary → payment monitoring. Billing and pathology workflows need to actually communicate: a claim held for a pending pathology result is better than one submitted on an assumption and corrected later. When pathology contradicts the original clinical impression — a lesion coded and billed as benign returns a malignant result, for example — the claim should be corrected and, where appropriate, resubmitted or appealed, not left as originally billed.

The 10 Costliest Excision Billing Process Failures

#	Failure	Operational Impact
1	Incorrect procedure classification	Wrong code family entirely — the largest possible coding error on this claim type
2	Incomplete measurement documentation	Coder can't confirm the correct size tier, risking downcoding or denial
3	Incorrect anatomical site grouping	Wrong code range selected despite correct size
4	Diagnosis mismatch	Medical necessity denial
5	Pathology reconciliation failure	Claim billed on an assumption that pathology later contradicts
6	Modifier misuse	Audit trigger, especially on multiple-procedure claims
7	Multiple-procedure edit failures	NCCI or payer edit denial on legitimately separate services
8	Missed eligible services	Legitimate closure or E/M services never billed
9	Unworked denials	Correctable revenue simply written off
10	Payment variance not identified	Underpayments against the contracted rate go uncollected

Revenue Leakage Audit

An Eight-Step Framework

1. Select a representative claim sample.

2. Compare clinical documentation against the billed CPT code.

3. Compare the billed CPT code against the diagnosis.

4. Review modifier usage for support and consistency.

5. Review payer adjudication outcomes.

6. Compare the allowed amount against the contracted expectation, where available.

7. Identify recurring process failures, not just individual claim errors.

8. Implement corrective action at the workflow level.

Dermatology Excision Revenue Integrity Dashboard

KPI	Why It Matters	Worsening Trend: Investigate
Clean Claim Rate	Share of claims accepted without correction	Which code family or site grouping is driving rejections
Denial Rate	Where claims are failing	Concentration by denial category
First-Pass Resolution	How much rework the process generates	Where rework concentrates
Net Collection Rate	Actual vs. allowable revenue collected	Contractual adjustments or unworked balances
Days in AR	How long payment takes to land	Which payer or claim type ages longest
Coding Accuracy	Independent audit agreement with billed codes	Measurement, family, or site-grouping errors specifically
Documentation Deficiency Rate	Notes missing a required element at audit	Which element is most often missing
Modifier Error Rate	Modifier use that isn't documentation-supported	Multiple-procedure and closure-modifier patterns specifically
Underpayment Rate	Payments below the contracted or expected rate	Payer- or code-specific variance
Appeal Success Rate	Appealed claims later paid	Whether appeals are being filed with adequate documentation

No universal benchmark percentages are listed here — they depend on payer mix, practice volume, and specialty focus. Track your own trend rather than an unsourced industry figure.

A 30-Day Excision Billing Improvement Plan

Days	Action	Owner
1–5	Baseline audit of a recent claim sample	RCM team
6–10	Documentation review against the checklist above	Providers + coding
11–15	Coding QA on the same sample	Coding team
16–20	Denial analysis by payer and category	Billing team
21–25	Workflow correction based on what was found	Management
26–30	Re-audit and measure the change	RCM leadership

AI and Technology in Excision Billing

Technology can support documentation review, coding-consistency checks, claim scrubbing, missing-information detection, denial categorization, and payment variance analysis — including flagging a likely measurement gap or an unsupported size-tier claim before submission. It shouldn't replace qualified human review for coding judgment, compliance decisions, medical necessity determinations, or genuinely ambiguous documentation — those remain decisions a certified coder or compliance professional makes and is accountable for.

What an Effective Excision Billing QA Program Looks Like

Pre-bill coding review, documentation validation against the checklist above, claim scrubbing tuned to this code family's specific edits, denial analysis that looks for root causes, payment posting with variance review built in, monthly audit sampling, and direct provider feedback when a documentation pattern recurs — that's the whole discipline. MedCloudMD's dermatology billing specialists build this exact workflow for practices that don't want to build and maintain it themselves.

Practical Excision Coding Scenarios

All scenarios below are hypothetical and illustrative — not actual MedCloudMD client results.

Scenario 1 — Small Benign Lesion, Documented Margins

A 0.4 cm benign lesion is excised from the forearm with a 0.3 cm margin on each side (excised diameter 1.0 cm). Coding consideration: 11401 (trunk/arms/legs, 0.6–1.0 cm). Billing risk: low, given complete measurement documentation. QA action: confirm simple closure isn't billed separately.

Scenario 2 — Malignant Lesion With Pathology

A lesion clinically suspected as basal cell carcinoma is excised and later confirmed by pathology. Coding consideration: code as benign with an indeterminate diagnosis until pathology returns, then correct to the appropriate malignant code once confirmed. Billing risk: coding malignant before confirmation. QA action: hold or flag the claim pending pathology rather than guessing.

Scenario 3 — Ambiguous Anatomical Location

An operative note documents “upper back” without specifying whether the site falls under the trunk grouping clearly enough for audit purposes. Coding consideration: trunk grouping applies, but documentation specificity matters under audit. QA action: request more precise site documentation as a standing template requirement, not just for this claim.

Scenario 4 — Multiple Lesions, One Session

Three benign lesions are excised from the trunk in one session, two requiring intermediate closure of the same type. Coding consideration: each excision coded separately (with modifier 59 or units per payer preference); the two same-type intermediate closures have their lengths added and billed as one closure code. Billing risk: billing each closure separately instead of combining. QA action: verify closure-length math before submission.

Scenario 5 — E/M Performed the Same Day

A patient scheduled for a planned excision also raises an unrelated new skin concern the provider fully evaluates separately. Coding consideration: the excision plus a separately documented E/M with modifier 25, if the new concern's evaluation is genuinely distinct from the procedure's own workup. QA action: confirm the E/M note stands on its own, independent of the procedure note.

Scenario 6 — Documentation Doesn't Support the Code Submitted

A 11403-level claim (2.1–3.0 cm) is submitted, but the operative note only documents a 1.5 cm lesion with no margin measurement recorded. Coding consideration: documentation only supports, at most, an estimate — not a specific tier. Billing risk: audit and recoupment exposure. QA action: hold the claim and request an addendum before submission, not after payment.

Key Takeaways

•     Excised diameter includes the margin on each side, not just the visible lesion — and it's measured before excision, not from the (shrunken) pathology specimen.

•     Pathology confirms benign vs. malignant status; the operative note sets the size tier.

•     Anatomical site grouping is as easy to get wrong as the size tier — and just as consequential.

•     Simple closure is always bundled; intermediate/complex is usually separate, except at the smallest size tier, where NCCI and CPT genuinely conflict.

•     Modifier 25 requires genuinely separate E/M documentation — not just a same-day encounter.

•     Same-type closures at grouped sites are added together and billed once, not per excision.

•     Diagnosis has to match documented reality, never a result assumed before pathology confirms it.

•     Most denials trace back to a documentation or measurement gap that existed before the claim was ever coded.

•     A recurring denial pattern is a workflow problem to fix once, not a queue of claims to resubmit individually.

Dermatology Excision Billing FAQ

What are CPT codes 11400–11446 used for?

They report excision of benign skin lesions, selected by anatomical site grouping and excised diameter (lesion plus margins).

How is the correct excision CPT code selected?

By four factors together: benign or malignant family, excised diameter, anatomical site grouping, and documentation that supports all three.

Does the excised diameter include the lesion margin?

Yes — it's the lesion's widest diameter plus the narrowest margin taken on each side, not the visible lesion alone.

How do benign and malignant excision codes differ?

Benign excisions use 11400–11446; malignant excisions use 11600–11646, confirmed by pathology. Both use the same site groupings and diameter-tier structure.

What documentation supports dermatology excision billing?

Lesion description, anatomical site, pre-excision measurement, margins, excised diameter, procedure performed, medical necessity, and closure type, at minimum.

Can an E/M visit and excision be billed on the same day?

Yes, with modifier 25, but only when a significant, separately identifiable E/M service is performed and documented distinctly from the procedure itself.

When should a modifier be considered for multiple procedures?

When multiple, genuinely distinct excisions or services are performed in the same session and the documentation supports each as separate — not as a default for every multi-procedure claim.

How does pathology affect excision billing?

It confirms benign vs. malignant status, which sets the code family; it doesn't determine the size tier, which comes from the pre-excision operative measurement.

What's the difference between excision and biopsy coding?

Excision is full-thickness removal of the entire lesion with margins; biopsy is diagnostic sampling without a definitive diagnosis yet established. They're coded from entirely different code ranges.

How can dermatology practices reduce excision claim denials?

Standardize pre-excision measurement documentation, reconcile pathology against the claim before submission, and audit modifier and closure logic regularly.

How often should dermatology excision claims be audited?

A representative monthly sample catches most patterns early; a more comprehensive quarterly review is reasonable for higher-volume practices.

Can an RCM company help identify dermatology revenue leakage?

Yes — a structured audit comparing documentation, coding, modifiers, and payment against expected rates typically surfaces both denial patterns and underpayments a practice's own claim-level review would miss.

This guide is based on AMA CPT excision and repair coding guidelines, Medicare NCCI policy manual provisions for integumentary procedures, and commonly published Medicare LCD/coverage articles for lesion excision. Confirm current NCCI edits, LCD requirements, and payer-specific policy before submitting claims — the closure bundling conflict discussed above in particular is worth reverifying periodically.

Medical Billing Disclaimer: This article is for general educational purposes only. CPT coding, reimbursement, coverage, and documentation requirements vary by payer, plan, jurisdiction, and individual patient circumstances, and can change without notice. Always verify current CPT guidance, NCCI edits, payer policy, and documentation standards before submitting claims. This content is not legal, coding, compliance, or medical advice, and the illustrative examples and KPIs in this guide are frameworks to adapt with your own data, not guarantees of any outcome or reimbursement amount.